Bioage Labs director acquires $4.3m in common stock
In a recent series of transactions, BioAge Labs, Inc. (NYSE:BIOA) director Vijay Satyanand Pande has significantly increased his stake in the company. The director acquired a total of $4.3 million worth of common stock over a span of three days, …